Presentation and outcome of infective endocarditis in Spain: a retrospective study  by Roca, Bernardino & Marco, Jose Manuel
Presentation and outcome of infective endocarditis
in Spain: a retrospective study
Bernardino Roca *, Jose Manuel Marco
Division of Infectious Diseases, Department of Medicine, Hospital General de Castello´n,
University of Valencia, 12004 Castello´n, Spain
Received 19 October 2005; received in revised form 27 February 2006; accepted 20 April 2006
Corresponding Editor: Raymond A. Smego, Sohar, Oman
International Journal of Infectious Diseases (2007) 11, 198—203
http://intl.elsevierhealth.com/journals/ijid
KEYWORD
Infective endocarditis
Summary
Objective: To analyze cases of infective endocarditis in patients who attended the Hospital
General de Castello´n, Spain, between 1999 and 2004.
Methods: This was a retrospective study. Demographic and clinical characteristics were assessed,
variation in presentation over time was analyzed, and factors influencing outcome were
determined.
Results: A total of 54 cases in 48 patients were included; 33 (61%) were in men. The median
patient age was 62 years. Infective endocarditis occurred on a native valve in 36 cases (67%), a
mechanical prosthetic valve in 12 (22%), and a pacemaker in six (11%). The mitral valve was the
most commonly affected site. Transthoracic and/or transesophageal echocardiography showed a
vegetation in 45 (83%) cases, moderate or severe valvular regurgitation in 27 (50%), and
intracardiac destructive lesions in five (9%). The outcome in 15 (28%) cases was death, and
multivariate analysis disclosed significantly increased risk of death associated with older age,
lower serum albumin, and higher white blood cell count.
Conclusions: This study confirmed the protean nature of infective endocarditis, and identified
several factors predictive of mortality including advanced age, low serum albumin, and high
white blood cell count.
# 2006 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights
reserved.Introduction
Over the years, the annual incidence of infective endocardi-
tis (IE) has remained basically stable, with some five cases per
100 000 person-years.1,2 By contrast, the causative agents
and the clinical presentation have changed considerably.3—5* Corresponding author. Tel.: +34 964 240854.
E-mail address: brocav@meditex.es (B. Roca).
1201-9712/$32.00 # 2006 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2006.04.002The main reason for this is the substantial modification in the
conditions predisposing to IE that has taken place: preva-
lence of rheumatic valvular disease has declined, and the use
of invasive diagnostic and therapeutic procedures has dra-
matically increased.6 Other factors, such as intravenous drug
use (IVDU)7 or older age of patient population,8,9 have also
influenced this shift. Moreover, compliance with recommen-
dations for IE prevention in subjects at-risk1 may also have
played a role.Published by Elsevier Ltd. All rights reserved.
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Figure 1 Incidence of infective endocarditis at the Hospital
General de Castello´n, 1999—2004.Historically, Streptococcus spp have been the main cau-
sative microorganisms of IE. However, recently, other patho-
gens have gained importance.10 Staphylococcus aureus,
especially in IVDU-related IE,11 and coagulase-negative sta-
phylococci, especially in prosthetic valve and pacemaker
IE,12,13 are now common etiologies. Culture-negative IE is
also recognized as an important clinical entity.14,15
If left untreated IE is generally fatal.16 The availability of
ultrasound examination17 and improvement in surgical tech-
niques18 over the past years have substantially increased the
diagnostic accuracy and treatment options in IE. Despite this,
more than a half of patients suffer serious complications, and
the mortality rate remains approximately 20% during the
initial hospitalization and approaches 40% at one year.18
Descriptive data regarding IE, including assessment of
change in presentation over time, are useful in determining
the impact of the disease and to optimize its management.
Recent research in the field from Spain is scant.14,19—21 We
undertook this study to describe the epidemiologic features
and clinical characteristics of IE, and to assess the changing
pattern of the disease over the last five years at our institu-
tion. We also tried to determine factors associated with IE-
related mortality.
Patients and methods
Study design
This study consisted of a retrospective analysis of all cases of
IE diagnosed at the Hospital General de Castello´n (HGC), from
January 1, 1999 to December 31, 2004. The HGC is a 600-bed
tertiary level teaching hospital that serves as a reference
center for the province of Castello´n, in the Comunidad
Valenciana, Spain.
Cases of IE were recovered with the help of the electronic
database of the Medical Records Department of the institu-
tion, which includes all admissions, classified in accordance
with the Spanish version of The International Classification of
Diseases, 9th Revision, Clinical Modification (ICD-9-CM).22 All
cases with ICD-9-CM codes 421 and 424 were initially
searched, and those that corresponded to IE were selected.
Medical charts belonging to the selected cases were
reviewed, and all cases that met the Duke diagnostic criteria
of IE23 were included in the study.
Study variables
From each case of IE the following demographic and clinical
variables were extracted: year of occurrence, patient age and
gender, length of hospital admission, underlying medical con-
dition, anatomic site or device, symptoms at presentation,
duration of symptoms before diagnosis, presence of heart
murmur, highest axillary temperature during hospitalization,
results of chest radiography, electrocardiography, transthor-
acic echocardiography (TTE) and/or transesophageal echocar-
diography (TEE), blood cultures, complete blood count and
differential, renal function tests, CD4+ cell count testing, HIV
RNA (if HIV seropositive), and urinalysis, antibiotics prescribed
before and after IE diagnosis, surgical treatment, complica-
tions, and outcome. Throughout the study period, cardiac
surgerywasavailable ina referencecenter, butnotat theHGC.Statistical analyses
A Little’s MCAR test was used to assess deviation from
randomness for missing values of study variables. Continuous
variables were summarized as median and interquartile
range (IQR). For univariate analyses, the Chi-square or Fish-
er’s exact test (for discrete variables) and Mann—Whitney U
test (for continuous variables) were used, where appropri-
ate. Variation among years during the study period was
assessed using Chi-square for discrete variables and Krus-
kal—Wallis for continuous variables. A multivariate, stepwise
logistic regression analysis was carried out to assess the
possible association between outcome and selected study
variables. Independent variables analyzed as predictors
included: gender, age, year of IE occurrence, duration of
hospitalization, IVDU, duration of symptoms before diagno-
sis, presence of heart murmur, highest axillary temperature,
length of vegetation, surgical treatment, serum creatinine,
albumin, white blood cell count, hemoglobin, and urinalysis.
The other study variables were not included because they
were believed to provide redundant information with other
included variables. After three steps, a test of the full model
against a constant-only model was statistically reliable
( p = 0.000), indicating that independent variables reliably
predicted the dependent variable. Variance in dependent
variables accounted by independent variables was good, with
Cox and Snell R2 = 0.521. Prediction success was also good
with 80% of dying cases and 95% of surviving cases correctly
predicted, for an overall success rate of 91%. All reported p
values were two-sided at the 0.05 significance level.
Results
Sociodemographic data
A total of 54 cases of IE were included in the study. Thirty-two
missing values on continuous variables were found with no
deviation from randomness ( p = 0.166), and were imputed
using the EM method. There were no missing values among
discrete variables. The 54 cases related to 48 patients: one
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Table 1 Underlying medical conditions among 54 cases of
infective endocarditis.
Medical condition No. of cases (%)
Non-valvular heart disease 19 (35)
Hypertension 16 (30)
Valvular heart disease 12 (22)
IVDU 11 (20)
Diabetes mellitus 11 (20)
Advanced renal failure 10 (18)
HIV infection 8 (1 5)
Stroke 8 (15)
Recent soft tissue infection 8 (15)
Hemodialysis 7 (13)
Recent biliary tract disease 5 (9)
Chronic gastrointestinal disease 5 (9)
Chronic liver disease 4 (7)
Chronic rheumatic disease 4 (7)
Tuberculosis 3 (6)
COPD 3 (6)
Alcohol abuse 2 (4)
Cancer 2 (4)
Recent surgery 2 (4)
IVDU, intravenous drug use; COPD, chronic obstructive pulmonary
disease.
Table 3 Distribution of causative microorganisms for cases
Table 2 Presenting symptoms of infective endocarditis
Symptom No. of cases (%)
Fever 47 (87)
Fatigue 14 (26)
Loss of appetite 11 (20)
Breathlessness 10 (18)
Encephalopathy 6 (11)
Chest pain 5 (9)
Focal neurologic symptoms 3 (6)patient had three episodes of IE, and four patients had two
episodes. Figure 1 shows the incidence of IE, by year, during
the study period. The overall median age of patients was 62
years (IQR 39—71, range 22—84). Thirty-three cases (61%)
were in men and 21 (39%) were in women. The median
duration of hospitalization was 28 days (IQR 16—48).
Medical antecedents
Table 1 summarizes the medical antecedents that were
present in study cases. The prevalence of IVDU (Figure 2)
diminished during the study period ( p = 0.073); the number
of IVDU cases in the first three years of the study was greaterFigure 2 Prevalence of intravenous drug use among cases of
infective endocarditis, 1999—2004.than during the last three years ( p = 0.043). IVDU was
reported in six of eight HIV-infected patients. Only five cases
(9%) had no underlying medical conditions.
Clinical features
IE involved native valves in 36 cases (67%), mechanical
prosthetic valves in 12 (22%), and pacemakers in six (11%).
The site of anatomic involvement was as follows: mitral valve
in 23 cases (43%), aortic valve in 13 (24%), tricuspid valve in
10 (18%), and a pacemaker in six (11%). The location of the
infection could not be determined in two cases (4%).
Table 2 summarizes the presenting symptoms of IE. Symp-
toms were present a median of 17 days (IQR 7—30) before the
diagnosis of IE was established. Physical examination
revealed a systolic murmur in 27 cases (50%), a diastolic
murmur in two (4%), a systolic—diastolic murmur in two (4%),
and no murmur in 23 (43%). The median highest axillary
temperature during hospitalization was 38.5 8C (IQR 38—
39). In three cases (6%), the temperature remained below
37 8C throughout the episode. Other physical examination
findings related to IE included: signs of heart failure, 10 cases
(18%), Janeway lesions, three cases (6%), petechiae, one case
(2%), and Osler’s nodes, one case (2%).of infective endocarditis
Microorganism No. of cases (%)a
Viridans streptococci 8 (15)
Streptococcus bovis 5 (9)
Streptococcus agalactiae 3 (6)
Streptococcus pyogenes 1 (2)
Enterococcus faecalis 3 (6)
Gemella haemolysans 1 (2)
Micrococcus spp 1 (2)
Rhodococcus equi 1 (2)
Staphylococcus aureus 11 (20)
Staphylococcus epidermidis 7 (13)
Staphylococcus warneri 1 (2)
Corynebacterium spp 1 (2)
Clostridium spp 2 (4)
Escherichia coli 2 (4)
Klebsiella pneumoniae 1 (2)
Culture-negative 10 (18)
a In four cases, two microorganisms were recovered from blood
cultures.
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Table 4 Logistic regression analysis of outcome (died or survived) as a function of independent variables
Predictors B Wald p OR CI
Step 1 Serum albumina 0.328 11.843 0.001 0.720 0.597—0.868
Step 2 Agea 0.089 9.553 0.002 1.093 1.033—1.156
Serum albumin 1.992 11.582 0.001 0.136 0.043—0.430
Step 3 Age 0.091 8.418 0.004 1.095 1.030—1.165
Serum albumin 2.797 13.751 0.000 0.061 0.014—0.268
WBCa 0.202 7.210 0.007 1.224 1.056—1.419
B, regression coefficient; p, significance of Wald; OR, odds ratio; CI, 95% confidence interval of odds ratio; WBC, white blood cell count.
a Predictor entered at each step.Diagnostic procedures
Chest radiographs revealed cardiomegaly in 10 cases (18%),
pleural effusion in eight (15%), diffuse bilateral interstitial
infiltrates in eight (15%), bilateral nodular infiltrates in five
(9%), and a unique lobular infiltrate in one (2%). All radio-
graphs with bilateral nodular infiltrates belonged to cases of
tricuspid valve or pacemaker IE. Chest radiographs showed
no abnormalities in 25 patients (46%). Electrocardiography
(EKG) showed an abnormality in 14 (26%) cases. These
abnormalities included atrial fibrillation in nine cases
(17%), right or left bundle branch block in three (6%), left
ventricular hypertrophy in two (4%), sinus tachycardia in
two (4%), and non-paroxysmal junctional tachycardia in
one (2%).
All patients underwent TTE (49 cases, or 91%) and/or TEE
(26 cases, or 48%). Transthoracic echocardiography was
abnormal in 42 cases (78%), and TEE abnormal in 23 cases
(43%). Transesophageal echo was abnormal in five of the
seven cases who had a normal TTE. Vegetations were
detected in 45 cases (83%), and had a median length of
0.9 mm (IQR 5—1.62). Other echocardiogram findings
included moderate or severe valvular regurgitation in 27
cases (50%), intracardiac destructive lesions in five (9%),
>1 vegetation in three (6%), moderate-to-severe pericardial
effusion in three (6%), pulmonary hypertension in two (4%),
and thrombus in an atrial appendage in one (2%).
Table 3 shows the distribution of the causative pathogens
of IE.
Blood and urine analysis results
Blood analysis revealed anemia in 39 cases (72%), renal
dysfunction in 26 (48%), and hypoalbuminemia in 26 (48%).
Urinalysis showed an abnormal sediment in nine (17%) cases,
proteinuria in five (9%), abnormal sediment plus proteinuria
in 21 (39%), and other abnormalities in two (4%). Seventeen
(31%) cases had a normal urinalysis.
Management and outcome
In 34 instances (63%), patients received antibiotics before the
diagnosis of IE was established. Persistently negative blood
cultures occurred as commonly in patients who received
antibiotics before the diagnosis of IE as in those who did
not ( p = 0.830). The empiric antibiotics most frequently used
for suspected endocarditis (prior to diagnosis) were beta-
lactams (15 cases, 28%), aminoglycosides (12 cases, 22%),vancomycin (eight cases, 15%), and fluoroquinolones (six
cases, 11%).
After establishing a diagnosis of IE, all patients received
antibiotic treatment. In 50 cases (93%), patients received
antimicrobial therapy recommended in published guide-
lines.1 Two cases with S. aureus IE were successfully treated
with teicoplanin. One case with negative blood cultures was
successfully treated with amoxicillin—clavulanate. A second
patient whose blood cultures were consistently negative was
treated with vancomycin plus levofloxacin plus clarithromy-
cin but he died. Surgical treatment of IE was carried out in
only eight cases (15%); in three patients the surgical proce-
dure consisted of pacemaker extraction only.
Complications of IE included heart failure in 18 cases
(33%), mycotic aneurism in eight (15%) (six of them affected
the brain), moderate-to-severe renal failure in three (6%),
moderate-to-severe pericardial effusion in two (4%), pleural
emphysema in one (2%), and myocardial infarction in one
(2%). The outcome in 15 (28%) cases was death, in 25 (46%) it
was cure and discharge, and in 14 (26%) cases discharge with
medical sequelae related to IE. Using multivariate analysis,
significant associations were found between dying as an
outcome and older age, lower serum albumin, and higher
white blood cell count (Table 4). No association was found
with the other variables assessed.
Discussion
There is a paucity of published data on infective endocarditis
in Spain. Our study confirmed many clinical features of
endocarditis occurring in other parts of the world. For exam-
ple, most cases of IE involved native valves and the mitral
valve was most commonly affected. Several series, however,
have found aortic valve involvement to be more fre-
quent.24,25 Fever was the most prevalent symptom among
our study cohort, although it was not reported by patients in
13% of cases. Thus, the lack of fever should not exclude a
diagnosis of IE in a patient with suggestive clinical fea-
tures.3,24 As noted previously, in most of our cases clinical
manifestations were present for weeks before the diagnosis
of IE was made, and other investigators have reported even
more prolonged duration of symptoms before presenta-
tion.3,26 The absence of a heart murmur in patients with IE
has also been described before, although the proportion of
cases without heart murmur (43%) was much higher in our
series than in others.3 Our patients also had a very low rate of
cutaneous manifestations (9%) compared to most patient
series.11,24,25
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series.1 Recent reports of radiographic and electrocardio-
graphic findings in IE are scant. Chest radiographs revealed
abnormalities in most of our patients, although such abnorm-
alities were diverse and non-specific. EKG demonstrated only
unimportant abnormalities, in a minority of cases. Although
these two tests seem to be of little help in the diagnosis of IE,
they are invaluable to diagnose multiple complications of the
disease, therefore they should be routinely performed in
every patient.27,28 Non-specific blood and urine abnormal-
ities were common (25—50% of cases) among our patients,
and reflected those well-described for endocarditis including
anemia, leukopenia or leukocytosis, thrombocytopenia, azo-
temia, proteinuria, and an active urinary sediment.
As reported recently, staphylococcal species have over-
taken streptococcal organisms as the most frequent causes of
native-valve endocarditis.11—13 We noted a comparable pro-
portion of our subjects with culture-negative endocarditis.3,4
Antibiotic treatment before the diagnosis of IE did not influ-
ence the rate of negative blood cultures in our study. The
most likely explanation is that, in many cases, such therapy
was properly started when the diagnosis of IE was only
suspected, days before the diagnosis was established. Anti-
biotic treatment after the diagnosis of IE was appropriate in
most cases, but still there was a small percentage of
instances where therapy was not entirely adequate, accord-
ing to guidelines.1
In our study cohort, valve surgery was carried out in a
small proportion of patients compared to other studies,4,24
the result, at least in part, of the unavailability of cardiac
surgery at our institution. Accordingly, the morbidity and
mortality among our patients were comparable or greater to
those reported by other authors.10,17,24,29 Where indicated,
surgical intervention has been demonstrated to improve the
prognosis of IE,1,25,29,30 and increasing the availability of such
treatment at our hospital may prove valuable in our patient
management.
Multivariate analysis disclosed an increased risk of death
from endocarditis with older age, decreased serum albumin,
and a high level of white blood cell count. Due to the retro-
spective nature of our study and the relatively small number
of cases, we may have failed to identify other important
prognostic factors. Other studies in this field have reached
conclusions similar to ours, regarding factors associated with
mortality.3,9,30—32 However, there are also studies that have
found other factors associated with mortality, such as severe
sepsis,16 heart failure,33,34 failure of antibiotic treatment,34
presence of diabetes mellitus,35 infection caused by S. aur-
eus35 or evidence of dissemination of the disease.25,34,35
Differences in design among studies and lack of uniformity
in analyzed variables may explain the discrepancies.
The inclusion of relapse cases may have slightly biased and
overstated the frequency of underlying medical conditions in
our patients. Many conditions present in our study subjects,
such as valvular heart disease, hemodialysis, and IVDU are
well known predisposing factors for the development of
IE.4,21,36—38 The decreasing prevalence of IVDU over our study
period is likely a consequence of the reduction in parenteral
drug use that has taken place in the Castello´n area in recent
years.39 HIV infection was present in 15% of cases, although
IVDU was present in most of those cases. These data agree
with those of other studies concluding that, in HIV-infectedpersons, IE is more closely associated with IVDU than with HIV
itself.27,36,40 The prolonged duration of hospitalization in our
cases, similar to that reported in other studies,24 denotes an
important cost burden and a need for home- or outpatient-
based management, where appropriate.
In summary, IE has long been described as a disease with
protean manifestations and substantial morbidity and mor-
tality.41 This study emphasizes such characteristics, and
provides insights regarding prognostic determinants for the
condition.
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